Jul 22, 2014 by Michael Douglass and Dave WilliamsonDid 3 Judges Just Start the Obamacare Death Spiral?Huge news for the Affordable Care Act
Jul 21, 2014 by Michael Douglass and Dave WilliamsonGilead Earnings: Can Sovaldi Reach $3 Billion?Sovaldi beat analyst expectations last quarter -- could it again?
Jul 21, 2014 by Michael Douglass and Dave Williamson1 Key Way Obamacare Could Help Johnson & Johnson StockJohnson & Johnson has an interesting opportunity with the insurance overhaul.
Jul 20, 2014 by Michael Douglass and Dave Williamson3 Ways to Cut Medicare SpendingMedicare spending is a big long-term concern. Here are three ways we could reduce it.
Jul 19, 2014 by Michael Douglass and Dave WilliamsonInvesting to Fight Toilet and Elevator SuperbugsThey're everywhere. Here's how we're fighting back.
Jul 19, 2014 by Michael Douglass and Dave WilliamsonDid We Just Unlock the Secret to Cutting Cancer Costs?Has UNH found something that could be incredibly useful here?
Jul 18, 2014 by Michael Douglass and Dave Williamson3 Crucial Questions Johnson & Johnson Needs to AnswerHere are three things investors need to know post-earnings.
Jul 18, 2014 by Michael Douglass and Dave WilliamsonGilead Sciences Stock's Huge Hidden OpportunityForget Sovaldi. This could be even bigger.
Jul 18, 2014 by Michael Douglass and Dave Williamson3 Key Opportunities to Watch for UnitedHealth Group StockUNH reported a great second quarter. Here are three things investors should watch for moving forward.
Jul 18, 2014 by Michael DouglassAsk a Fool: Time to Buy Sirona Dental Systems Stock?Is Sirona a great stock for a portfolio? Watch below for a Motley Fool analyst's take.
Jul 17, 2014 by Michael Douglass and Dave Williamson3 Key Takeaways from UnitedHealth Group Stock EarningsHere's what you need to know.
Jul 16, 2014 by Michael Douglass and Dave WilliamsonGilead Stock Earnings: What to WatchWhen Gilead reports earnings, here's what you should keep an eye on.
Jul 16, 2014 by Michael Douglass and Dave WilliamsonA Surprising Johnson & Johnson Stock Growth Driver, RevealedAnd it's not Olysio!
Jul 14, 2014 by Michael Douglass and Dave Williamson$5.3 Billion Deal: Should Mylan Stock Investors Cheer or Jeer?Mylan just signed a huge deal with Abbott Labs -- was it a good or a bad move?
Jul 14, 2014 by Michael Douglass and Dave WilliamsonUp 23%: Time to Buy Exelixis?A great day today, but is it time to buy?
Jul 14, 2014 by Michael Douglass and Dave Williamson3 Huge Benefits Kindred Offers GentivaAside from the premium!
Jul 13, 2014 by Michael Douglass and Dave WilliamsonIs Becoming France the Answer to Medicare's Biggest Problem?France has found an interesting way to save money on health care expenses. Read below for more.
Jul 13, 2014 by Michael Douglass and Dave Williamson2.5 Billion People Threatened by This Disease: How We're Fighting BackAnd how a company can do well by doing good.
Jul 11, 2014 by Michael Douglass and Dave WilliamsonFrance Not Retreating from Gilead SciencesThe pushback against Sovaldi's price gets even stronger
Jul 10, 2014 by Michael Douglass and Dave WilliamsonAre These the Best Big Biotech Stocks for Your Portfolio?Watch below for more on this story.
